Illumina teams up with Tempus to expand DNA profiling beyond cancer

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease.  | The companies said they will work together to train artificial intelligence algorithms on genomic data, while also collecting evidence on the clinical benefits of molecular diagnostics and comprehensive genomic profiling in everyday healthcare.